Pendence of JNK and ERK activation. Treatment of HepG2 cells with

Pendence of JNK and ERK activation. Treatment of HepG2 cells with the JNK inhibitor SP600125 prevented DCLF/IFN-mediated phosphorylation of STAT-1 at Ser 727 (Figure 8A). Moreover, treatment with SP600125 significantly reduced DCLF-induced activation of ERK (Figure 8B). Aspirin Does Not Promote Activation of JNK or ERK, or the ER Stress Sensor, PERK The results above suggest that DCLF-induced activation of JNK, ERK, and the ER stress sensor PERK is required for cytotoxic synergy mediated by DCLF/cytokine cotreatment. Aspirin is an NSAID that is not associated with human IDILI, and it does not synergize with cytokines to kill HepG2 cells (Maiuri et al., 2015). To evaluate the specificity of the IDILI-associated drug DCLF in activating these pathways, we evaluated whether aspirin treatment promotes activation of JNK, ERK, and PERK. Theconcentration of aspirin chosen relative to its maximal plasma concentration observed in human patients (Cmax) is comparable to that chosen for DCLF relative to its Cmax (Brandon et al., 1986; Xu et al., 2008). Treatment of HepG2 cells with aspirin did not result in activation of any of these factors (Figure 9).DISCUSSIONWe and others have shown that DCLF synergizes with cytokines to cause cytotoxicity in human primary hepatocytes (Cosgrove et al., 2009) and HepG2 cells (Fredriksson et al., 2011; Maiuri et al., 2015) by a mechanism involving the MAPKs, JNK, and ERK. Moreover, Fredriksson et al. (2014) reported that DCLF caused activation of the ER stress pathway in HepG2 cells as early as 2 h after treatment, and this response was unaffected by TNF but was required for DCLF/TNF-induced cytotoxic synergy. In addition, DCLF induced a delayed increase in intracellular Ca�� inMAIURI ET AL.|transformed human hepatocytes after 6 h of exposure (Lim et al., 2006). Moreover, others have shown that cytokine treatment can also promote an increase in intracellular Ca�� (Chang et al., 2004; Delmotte et al., 2012). Similarly, we demonstrated in HepG2 cells that DCLF promotes a delayed increase in intracellular Ca��, and this increase was enhanced by treatment with TNF/IFN (Figure 1). Since ER stress is strongly associated with promoting increases in intracellular Ca��, and since DCLF treatment can induce both of these Quizartinib price responses in liver cells, we AG-490 chemical information hypothesized that Ca�� contributes to DCLF/cytokine-induced cytotoxic synergy. Chelation of intracellular Ca�� markedly reduced cytotoxicity and caspase-3 activation induced by DCLF/cytokine treatment (Figure 2), whereas removal of extracellular Ca�� did not affect the cytotoxic interaction (Supplementary Figure 1). These findings suggest that Ca�� released from an intracellular source underlies the cytotoxic interaction mediated by DCLF/cytokine cotreatment. Ca�� is primarily stored in the ER, but it can also be stored in other intracellular compartments including the mitochondria (Berridge et al., 1998). Ryanodine receptors and IP3 receptors are the most well-characterized Ca�� channels localized to the ER membrane. Moreover, IP3 receptor activation is associated with Ca��-mediated apoptosis via the intrinsic (mitochondrial) pathway (Deniaud et al., 2008; Verrier et al., 2004). 2-APB, a commonly used IP3 receptor antagonist, greatly reduced the cytotoxic interaction mediated by DCLF/TNF cotreatment, prevented the IFN-mediated enhancement of cytotoxicity, and reduced DCLF/ cytokine-induced caspase-3 activation (Figure 3), suggesting that these responses require IP3 receptor activation. Thi.Pendence of JNK and ERK activation. Treatment of HepG2 cells with the JNK inhibitor SP600125 prevented DCLF/IFN-mediated phosphorylation of STAT-1 at Ser 727 (Figure 8A). Moreover, treatment with SP600125 significantly reduced DCLF-induced activation of ERK (Figure 8B). Aspirin Does Not Promote Activation of JNK or ERK, or the ER Stress Sensor, PERK The results above suggest that DCLF-induced activation of JNK, ERK, and the ER stress sensor PERK is required for cytotoxic synergy mediated by DCLF/cytokine cotreatment. Aspirin is an NSAID that is not associated with human IDILI, and it does not synergize with cytokines to kill HepG2 cells (Maiuri et al., 2015). To evaluate the specificity of the IDILI-associated drug DCLF in activating these pathways, we evaluated whether aspirin treatment promotes activation of JNK, ERK, and PERK. Theconcentration of aspirin chosen relative to its maximal plasma concentration observed in human patients (Cmax) is comparable to that chosen for DCLF relative to its Cmax (Brandon et al., 1986; Xu et al., 2008). Treatment of HepG2 cells with aspirin did not result in activation of any of these factors (Figure 9).DISCUSSIONWe and others have shown that DCLF synergizes with cytokines to cause cytotoxicity in human primary hepatocytes (Cosgrove et al., 2009) and HepG2 cells (Fredriksson et al., 2011; Maiuri et al., 2015) by a mechanism involving the MAPKs, JNK, and ERK. Moreover, Fredriksson et al. (2014) reported that DCLF caused activation of the ER stress pathway in HepG2 cells as early as 2 h after treatment, and this response was unaffected by TNF but was required for DCLF/TNF-induced cytotoxic synergy. In addition, DCLF induced a delayed increase in intracellular Ca�� inMAIURI ET AL.|transformed human hepatocytes after 6 h of exposure (Lim et al., 2006). Moreover, others have shown that cytokine treatment can also promote an increase in intracellular Ca�� (Chang et al., 2004; Delmotte et al., 2012). Similarly, we demonstrated in HepG2 cells that DCLF promotes a delayed increase in intracellular Ca��, and this increase was enhanced by treatment with TNF/IFN (Figure 1). Since ER stress is strongly associated with promoting increases in intracellular Ca��, and since DCLF treatment can induce both of these responses in liver cells, we hypothesized that Ca�� contributes to DCLF/cytokine-induced cytotoxic synergy. Chelation of intracellular Ca�� markedly reduced cytotoxicity and caspase-3 activation induced by DCLF/cytokine treatment (Figure 2), whereas removal of extracellular Ca�� did not affect the cytotoxic interaction (Supplementary Figure 1). These findings suggest that Ca�� released from an intracellular source underlies the cytotoxic interaction mediated by DCLF/cytokine cotreatment. Ca�� is primarily stored in the ER, but it can also be stored in other intracellular compartments including the mitochondria (Berridge et al., 1998). Ryanodine receptors and IP3 receptors are the most well-characterized Ca�� channels localized to the ER membrane. Moreover, IP3 receptor activation is associated with Ca��-mediated apoptosis via the intrinsic (mitochondrial) pathway (Deniaud et al., 2008; Verrier et al., 2004). 2-APB, a commonly used IP3 receptor antagonist, greatly reduced the cytotoxic interaction mediated by DCLF/TNF cotreatment, prevented the IFN-mediated enhancement of cytotoxicity, and reduced DCLF/ cytokine-induced caspase-3 activation (Figure 3), suggesting that these responses require IP3 receptor activation. Thi.